Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,526,543
-
Share change
-
-36,813
-
Total reported value
-
$3,909,456
-
Price per share
-
$2.56
-
Number of holders
-
20
-
Value change
-
-$111,033
-
Number of buys
-
5
-
Number of sells
-
11
Institutional Holders of ACER THERAPEUTICS INC - COM (ACER) as of Q3 2021
As of 30 Sep 2021,
ACER THERAPEUTICS INC - COM (ACER) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,526,543 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, STATE STREET CORP, XTX Topco Ltd, NORTHERN TRUST CORP, and RAYMOND JAMES & ASSOCIATES.
This page lists
20
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.